Notice2026-00074
National Human Genome Research Institute; Notice of Closed Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 7, 2026
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 4 (Wednesday, January 7, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 4 (Wednesday, January 7, 2026)]
[Notices]
[Pages 513-514]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-00074]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Human Genome Research Institute; Notice of Closed
Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Advisory
Council for Human Genome Research.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council for Human Genome
Research.
Date: February 10, 2026.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Address: National Human Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive, Suite 1100, Rockledge,
MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Issel Anne Lim, Ph.D., Deputy Director, Division
of Extramural
[[Page 514]]
Operations, National Human Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive, Room 3186, Bethesda, MD
20892, <a href="/cdn-cgi/l/email-protection#244d57574148454a4a410a484d49644a4d4c0a434b52"><span class="__cf_email__" data-cfemail="167f6565737a77787873387a7f7b56787f7e38717960">[email protected]</span></a>.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: <a href="http://www.genome.gov/council">http://www.genome.gov/council</a>, where an agenda and any
additional information for the meeting will be posted when
available.
Dated: January 5, 2026.
Bruce A. George,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2026-00074 Filed 1-6-26; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on January 7, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.